Parataxis Holdings to Go Public via Business Combination with SilverBox Corp IV

Abra Financial Holdings to Go Public via SPAC Merger with New Providence Acquisition Corp. III

March 16, 2026

Financial Services

Abra Financial Holdings announced plans to become a publicly traded company through a business combination with special purpose acquisition company New Providence Acquisition Corp. III. The deal values Abra at a $750 million pre-money equity valuation and is expected to provide growth capital, with shares expected to trade on Nasdaq under ticker ABRX after closing.

BD Acquires Parata Systems

July 18, 2022

Medical Devices

BD (Becton, Dickinson and Company) has completed its acquisition of Parata Systems, a provider of pharmacy automation and medication management solutions. The deal brings Parata into BD's Medication Management Solutions business to expand BD's smart, connected care capabilities across retail, hospital and long-term care pharmacies.

Colonnade Acquisition Corp. II to Take Plastiq Public via Business Combination

August 4, 2022

Payments & Fintech

Plastiq Inc., a B2B payments platform for small and midsize businesses, has entered into a definitive merger agreement with special purpose acquisition company Colonnade Acquisition Corp. II to take Plastiq public. The combined company will operate as Plastiq with an implied enterprise value of approximately $480 million at closing and is expected to add about $320 million of cash to the balance sheet to support organic and inorganic growth.

SAB Biotherapeutics to Go Public via Merger with Big Cypress Acquisition Corp.

October 20, 2021

Biotechnology

SAB Biotherapeutics entered into a definitive business combination/merger agreement with Big Cypress Acquisition Corp. (a SPAC), with the combined company to operate as SAB Biotherapeutics and be listed on Nasdaq. Big Cypress stockholders approved the deal, and the transaction was expected to close on or about October 22, 2021, subject to customary conditions.

Mountain Crest Acquisition Corp II Completes Business Combination with Better Therapeutics

October 29, 2021

Healthcare Services

Mountain Crest Acquisition Corp II completed a business combination with Better Therapeutics, taking the prescription digital therapeutics company public on Nasdaq under the ticker BTTX. The transaction generated approximately $70 million in gross proceeds (including a PIPE led by Farallon Capital Management, RS Investments, Sectoral Asset Management and Monashee Investment Management) and included a contingent credit facility from Hercules Capital to fund clinical development and regulatory efforts for Better Therapeutics' lead product, BT-001.

BOXABL Merger with FG Merger II Corp. (SPAC) to Potentially Go Public

September 30, 2025

Consumer Products

BOXABL announced the release of a founder CEO video addressing questions about the company’s potential merger with FG Merger II Corp., a Nasdaq-listed SPAC. The transaction follows the filing of a registration statement on Form S-4 and would (if completed) result in BOXABL trading on Nasdaq under the ticker “BXBL.”